Chapter/Section Purchase

1 Study Coverage
1.1 Liposomes Product Introduction
1.2 Market by Type
1.2.1 Global Liposomes Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Liposomal Doxorubicin
1.2.3 Liposomal Amphoteracin B
1.2.4 Liposomal Paclitaxel
1.2.5 Others
1.3 Market by Application
1.3.1 Global Liposomes Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Fungal Infection Therapy
1.3.3 Cancer & Tumor Therapy
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Liposomes Sales Estimates and Forecasts 2017-2028
2.2 Global Liposomes Revenue Estimates and Forecasts 2017-2028
2.3 Global Liposomes Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Liposomes Sales by Region
2.4.1 Global Liposomes Sales by Region (2017-2022)
2.4.2 Global Sales Liposomes by Region (2023-2028)
2.5 Global Liposomes Revenue by Region
2.5.1 Global Liposomes Revenue by Region (2017-2022)
2.5.2 Global Liposomes Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Liposomes Sales by Manufacturers
3.1.1 Global Top Liposomes Manufacturers by Sales (2017-2022)
3.1.2 Global Liposomes Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Liposomes in 2021
3.2 Global Liposomes Revenue by Manufacturers
3.2.1 Global Liposomes Revenue by Manufacturers (2017-2022)
3.2.2 Global Liposomes Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Liposomes Revenue in 2021
3.3 Global Liposomes Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Liposomes Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Liposomes Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Liposomes Sales by Type
4.1.1 Global Liposomes Historical Sales by Type (2017-2022)
4.1.2 Global Liposomes Forecasted Sales by Type (2023-2028)
4.1.3 Global Liposomes Sales Market Share by Type (2017-2028)
4.2 Global Liposomes Revenue by Type
4.2.1 Global Liposomes Historical Revenue by Type (2017-2022)
4.2.2 Global Liposomes Forecasted Revenue by Type (2023-2028)
4.2.3 Global Liposomes Revenue Market Share by Type (2017-2028)
4.3 Global Liposomes Price by Type
4.3.1 Global Liposomes Price by Type (2017-2022)
4.3.2 Global Liposomes Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Liposomes Sales by Application
5.1.1 Global Liposomes Historical Sales by Application (2017-2022)
5.1.2 Global Liposomes Forecasted Sales by Application (2023-2028)
5.1.3 Global Liposomes Sales Market Share by Application (2017-2028)
5.2 Global Liposomes Revenue by Application
5.2.1 Global Liposomes Historical Revenue by Application (2017-2022)
5.2.2 Global Liposomes Forecasted Revenue by Application (2023-2028)
5.2.3 Global Liposomes Revenue Market Share by Application (2017-2028)
5.3 Global Liposomes Price by Application
5.3.1 Global Liposomes Price by Application (2017-2022)
5.3.2 Global Liposomes Price Forecast by Application (2023-2028)
6 North America
6.1 North America Liposomes Market Size by Type
6.1.1 North America Liposomes Sales by Type (2017-2028)
6.1.2 North America Liposomes Revenue by Type (2017-2028)
6.2 North America Liposomes Market Size by Application
6.2.1 North America Liposomes Sales by Application (2017-2028)
6.2.2 North America Liposomes Revenue by Application (2017-2028)
6.3 North America Liposomes Market Size by Country
6.3.1 North America Liposomes Sales by Country (2017-2028)
6.3.2 North America Liposomes Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Liposomes Market Size by Type
7.1.1 Europe Liposomes Sales by Type (2017-2028)
7.1.2 Europe Liposomes Revenue by Type (2017-2028)
7.2 Europe Liposomes Market Size by Application
7.2.1 Europe Liposomes Sales by Application (2017-2028)
7.2.2 Europe Liposomes Revenue by Application (2017-2028)
7.3 Europe Liposomes Market Size by Country
7.3.1 Europe Liposomes Sales by Country (2017-2028)
7.3.2 Europe Liposomes Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Liposomes Market Size by Type
8.1.1 Asia Pacific Liposomes Sales by Type (2017-2028)
8.1.2 Asia Pacific Liposomes Revenue by Type (2017-2028)
8.2 Asia Pacific Liposomes Market Size by Application
8.2.1 Asia Pacific Liposomes Sales by Application (2017-2028)
8.2.2 Asia Pacific Liposomes Revenue by Application (2017-2028)
8.3 Asia Pacific Liposomes Market Size by Region
8.3.1 Asia Pacific Liposomes Sales by Region (2017-2028)
8.3.2 Asia Pacific Liposomes Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Liposomes Market Size by Type
9.1.1 Latin America Liposomes Sales by Type (2017-2028)
9.1.2 Latin America Liposomes Revenue by Type (2017-2028)
9.2 Latin America Liposomes Market Size by Application
9.2.1 Latin America Liposomes Sales by Application (2017-2028)
9.2.2 Latin America Liposomes Revenue by Application (2017-2028)
9.3 Latin America Liposomes Market Size by Country
9.3.1 Latin America Liposomes Sales by Country (2017-2028)
9.3.2 Latin America Liposomes Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Liposomes Market Size by Type
10.1.1 Middle East and Africa Liposomes Sales by Type (2017-2028)
10.1.2 Middle East and Africa Liposomes Revenue by Type (2017-2028)
10.2 Middle East and Africa Liposomes Market Size by Application
10.2.1 Middle East and Africa Liposomes Sales by Application (2017-2028)
10.2.2 Middle East and Africa Liposomes Revenue by Application (2017-2028)
10.3 Middle East and Africa Liposomes Market Size by Country
10.3.1 Middle East and Africa Liposomes Sales by Country (2017-2028)
10.3.2 Middle East and Africa Liposomes Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Corporation Information
11.1.2 Johnson & Johnson Overview
11.1.3 Johnson & Johnson Liposomes Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Johnson & Johnson Liposomes Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Johnson & Johnson Recent Developments
11.2 Gilead Sciences
11.2.1 Gilead Sciences Corporation Information
11.2.2 Gilead Sciences Overview
11.2.3 Gilead Sciences Liposomes Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Gilead Sciences Liposomes Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Gilead Sciences Recent Developments
11.3 Pacira
11.3.1 Pacira Corporation Information
11.3.2 Pacira Overview
11.3.3 Pacira Liposomes Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Pacira Liposomes Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Pacira Recent Developments
11.4 Sun Pharmaceutical
11.4.1 Sun Pharmaceutical Corporation Information
11.4.2 Sun Pharmaceutical Overview
11.4.3 Sun Pharmaceutical Liposomes Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Sun Pharmaceutical Liposomes Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Sun Pharmaceutical Recent Developments
11.5 Luye Pharma
11.5.1 Luye Pharma Corporation Information
11.5.2 Luye Pharma Overview
11.5.3 Luye Pharma Liposomes Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Luye Pharma Liposomes Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Luye Pharma Recent Developments
11.6 Sigma-Tau Group
11.6.1 Sigma-Tau Group Corporation Information
11.6.2 Sigma-Tau Group Overview
11.6.3 Sigma-Tau Group Liposomes Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Sigma-Tau Group Liposomes Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Sigma-Tau Group Recent Developments
11.7 Fudan-Zhangjiang
11.7.1 Fudan-Zhangjiang Corporation Information
11.7.2 Fudan-Zhangjiang Overview
11.7.3 Fudan-Zhangjiang Liposomes Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Fudan-Zhangjiang Liposomes Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Fudan-Zhangjiang Recent Developments
11.8 Teva Pharmaceutical
11.8.1 Teva Pharmaceutical Corporation Information
11.8.2 Teva Pharmaceutical Overview
11.8.3 Teva Pharmaceutical Liposomes Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Teva Pharmaceutical Liposomes Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Teva Pharmaceutical Recent Developments
11.9 CSPC
11.9.1 CSPC Corporation Information
11.9.2 CSPC Overview
11.9.3 CSPC Liposomes Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 CSPC Liposomes Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 CSPC Recent Developments
11.10 Novartis
11.10.1 Novartis Corporation Information
11.10.2 Novartis Overview
11.10.3 Novartis Liposomes Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Novartis Liposomes Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Novartis Recent Developments
11.11 Kingond Pharm
11.11.1 Kingond Pharm Corporation Information
11.11.2 Kingond Pharm Overview
11.11.3 Kingond Pharm Liposomes Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Kingond Pharm Liposomes Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Kingond Pharm Recent Developments
11.12 Spectrum Pharmaceuticals
11.12.1 Spectrum Pharmaceuticals Corporation Information
11.12.2 Spectrum Pharmaceuticals Overview
11.12.3 Spectrum Pharmaceuticals Liposomes Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Spectrum Pharmaceuticals Liposomes Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Spectrum Pharmaceuticals Recent Developments
11.13 Shanghai New Asia
11.13.1 Shanghai New Asia Corporation Information
11.13.2 Shanghai New Asia Overview
11.13.3 Shanghai New Asia Liposomes Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Shanghai New Asia Liposomes Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Shanghai New Asia Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Liposomes Industry Chain Analysis
12.2 Liposomes Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Liposomes Production Mode & Process
12.4 Liposomes Sales and Marketing
12.4.1 Liposomes Sales Channels
12.4.2 Liposomes Distributors
12.5 Liposomes Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Liposomes Industry Trends
13.2 Liposomes Market Drivers
13.3 Liposomes Market Challenges
13.4 Liposomes Market Restraints
14 Key Findings in The Global Liposomes Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer